Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation

Authors not listed

University Hospital, Bordeaux · 2025

Abstract

Kidney transplantation (KT) benefit-risk ratio assessment is a challenge in a growing population of older patients with end-stage kidney disease. A pre-KT frailty phenotype has been found predictive of post-KT complications, but biological mechanisms of frailty are poorly known is these patients. Frailty is associated with chronic low-grade inflammation in the older general population, possibly through the inflammasome pathway. Our main objective is to assess if systemic activation of inflammasomes is associated with frailty in older candidates to KT.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-22 MST

Cite this

APA
Anonymous. (2025). Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation. <em>University Hospital, Bordeaux</em>. https://clinicaltrials.gov/study/NCT06887075
Vancouver
Anonymous. Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation. University Hospital, Bordeaux. 2025.
BibTeX
@misc{anon2025System, title = {Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation}, author = {Anonymous}, journal = {University Hospital, Bordeaux}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings